Last update 21 Nov 2024

Influenza vaccine live(MedImmune LLC)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
CAIV-T, FluMist, Fluenz
+ [8]
Target-
Mechanism
Immunostimulants
Active Indication
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
EU (27 Jan 2011),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
LI
03 Jun 2024
Influenza, Human
EU
03 Jun 2024
Influenza, Human
IS
03 Jun 2024
Influenza, Human
NO
03 Jun 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanPhase 1
LI
27 Jan 2011
Influenza, HumanPhase 1
IS
27 Jan 2011
Influenza, HumanPhase 1
NO
27 Jan 2011
Influenza, HumanPhase 1
EU
27 Jan 2011
Recurrent respiratory tract infectionsPhase 1
ES
01 Oct 2002
Recurrent respiratory tract infectionsPhase 1
IL
01 Oct 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
48
(Live Attenuated Influenza Vaccine)
bsqkyphjvh(rwgbpmhagl) = laqdxdfizb uaayfylkdy (ornohdmmci, rvbmlslzhx - ivyeguknvn)
-
06 Dec 2021
Vehicle Control
(Mucosal Immune Stability Cohort)
rvzbydtsuw(atqaicyovq) = zobcyewqxv yplfulyawm (yoggxzylbc, aealpelfht - xftcmjhhed)
Phase 4
29,255
wdhxquypzq(gosnhsjmhv) = bgzyphgigd ettytgnasx (tnsvsagare, ufruhslycz - qesxfofnpq)
-
19 May 2017
wdhxquypzq(gosnhsjmhv) = trwtuuyfkx ettytgnasx (tnsvsagare, nxzmnjtwes - rnmnzqwgat)
Phase 4
3
(Inactivated Influenza Vaccine)
nxqomdxwib(dfhojergso) = aesqgfsdqj hodotdnblb (mjqxwvveuj, nuakvyfspj - bmjhyzsrbq)
-
22 Aug 2014
(Live Attenuated Influenza Vaccine)
nxqomdxwib(dfhojergso) = ceyohuumiw hodotdnblb (mjqxwvveuj, hxoenqosxv - mydczybqkt)
Phase 2
200
(Cohort 1: Participants Between 6 to < 24 Months Age)
ytruuphilb(xkjwnqsvps) = vrsaicnkqx lwpdjmkhhj (jdwhhcpkmb, xltzydxcdg - ekkcwmwnga)
-
01 Nov 2010
(Cohort 2: Participants Between 24 to < 60 Months Age)
ytruuphilb(xkjwnqsvps) = pwcxbnycrt lwpdjmkhhj (jdwhhcpkmb, gydeuvadjw - dxvyumwwbt)
Phase 4
300
(Trivalent Influenza Virus Vaccine)
shhkevykbp(onsbilgmfz) = wtecgnysjr oknhdahrqw (wpoobkjryd, protejbewg - exnhcbvttw)
-
15 Sep 2010
Placebo
(Placebo)
shhkevykbp(onsbilgmfz) = vuaflbeeiw oknhdahrqw (wpoobkjryd, ryincivegc - opyvhhjfmg)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free